Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
absence, abstract, AgreementSM, ASCO, ASH, AstraZeneca, bromodomain, Chi, cohort, count, creatinine, cycle, durability, durable, dyspnea, fatal, female, Gale, guiding, Hb, imaging, ineligible, Kim, lab, male, malignant, metric, moved, Parliament, placement, poster, premalignant, proxy, refractory, resale, residence, serve, shelf, shifting, spontaneously, surrogate, TD, transplant, transplantation, TSS, TTP, underwent, universal, worse, young
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view